333 completed, 30 unknown, 21 withdrawn, 17 terminated. 128 Phase 3, 98 Phase 2, 81 Phase 4, 59 Not applicable, 26 Phase 1.
Follow Conjunctivitis: new trials by email Literature Review of Conjunctivitis trials Research Report on Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma Ivermectin - Survival of Flies Developing in Faecal Samples | Phase 4 | Not yet recruiting | London School of Hygiene and Tropical Medicine | 12 | 2026-10-05 | 2026-10-30 |
| Investigating Nasal and Ocular Immune Response to Conjunctival Allergen Exposure Standardized Allergen Extract, Timothy Grass (Phleum pratense) - Allergic Rhinoconjunctivitis | Recruiting | Dr. Anne Ellis | 12 | 2026-09-01 | 2026-10-01 | |
| A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy Noninterventional - Conjunctivitis Allergic | Not yet recruiting | Regeneron Pharmaceuticals | 1500 | 2026-08-17 | 2026-07-17 | |
| A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy REGN-2Cat, Freneslerbart, Mevonlerbart - Allergic Conjunctivitis | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 570 | 2026-07-31 | 2026-08-12 |
| Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis SUM-191, Placebo - Bacterial Conjunctivitis | Phase 1 / Phase 2 | Recruiting | Senju USA, Inc. | 426 | 2026-06-25 | 2026-06-30 |
| Daydrop® Triple Action for Allergic Eye Symptoms Eye Drops, Lubricant - Allergic Conjunctivitis of Both Eyes | Not applicable | Recruiting | i+Med S.Coop. | 49 | 2026-06-08 | 2026-09-04 |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED Cenegermin, Vehicle - Persistent Corneal Epithelial Defect | Phase 3 | Recruiting | Dompé Farmaceutici S.p.A | 150 | 2026-06-02 | 2026-10-07 |
| A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis Slit Lamp Examination, Far Best Corrected Visual Acuity (BCVA), T1695 - Moderate to Severe Vernal Keratoconjunctivitis | Phase 2 | Recruiting | Laboratoires Thea | 120 | 2026-03-24 | 2026-04-22 |
| 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis 3% Diquafosol ophthalmic solution and 0.1% Cyclosporin A cationic ophthalmic emulsion, 0.1% Cyclosporin A cationic ophthalmic emulsion - Vernal Keratoconjunctivitis | Phase 3 | Recruiting | The University of Hong Kong | 94 | 2026-02-09 | 2026-04-30 |
| RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs) B-RAP, BLTR - Trachoma, Eye Diseases | Not applicable | Recruiting | University of North Carolina, Chapel Hill | 1000 | 2026-01-13 | 2026-04-13 |
| Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy REGN5713, REGN5715, Placebo - Allergic Conjunctivitis | Phase 3 | Terminated | Regeneron Pharmaceuticals | 24 | 2026-01-10 | 2026-09-01 |
| OJO-miR: microRNA Expression in Allergic Conjunctivitis. Conjunctivitis, Allergic | Active not recruiting | Instituto de Oftalmología Fundación Conde de Valenciana | 40 | 2026-01-05 | 2026-02-04 | |
| Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy Conjunctivitis, Allergic | Not yet recruiting | Instituto de Oftalmología Fundación Conde de Valenciana | 60 | 2026-01-01 | 2025-09-17 | |
| Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects Allergic Rhinitis, Allergic Conjunctivitis | Not yet recruiting | Sven Schneider, MD | 152 | 2025-12-01 | 2025-05-07 | |
| A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease BRM421 Ophthalmic Solution, 0.03%, Artificial Tear, BRM421 Ophthalmic Solution, 0.06% - Dry Eye Disease (DED), Keratoconjunctivitis Sicca | Phase 2 | Not yet recruiting | BRIM Biotechnology Inc. | 99 | 2025-12-01 | 2025-10-20 |
| Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis TL-925, Placebo - Allergic Conjunctivitis | Phase 2 | Recruiting | Telios Pharma, Inc. | 60 | 2025-10-23 | 2025-11-25 |
| Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis Steroid eye drops, Tacrolimus eye drops - Vernal Keratoconjunctivitis | Not applicable | Not yet recruiting | Sohag University | 90 | 2025-09-01 | 2025-08-24 |
| Treatment of Ocular Surface Inflammations Topical Cyclosporine 1% - Ocular Surface Allergy, Conjunctivitis, Allergic | Recruiting | Semmelweis University | 50 | 2025-06-10 | 2026-08-03 | |
| Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed Reinnerva/Lubristil +G sterile eye drops (artificial tears), Vismed sterile eye drops (artificial tears) - Keratoconjunctivitis Sicca | Not applicable | Completed | Medivis SRL | 40 | 2025-06-09 | 2026-02-19 |
| Trachoma Elimination Study by Focused Antibiotic (TESFA) Azithromycin mass treatment, Azithromycin targeted treatment - Trachoma | Phase 4 | Withdrawn | Emory University | 2025-06-01 | 2025-07-16 |
Showing 20 of 429. Sign in to see all of them.
Conjunctivitis, Allergic (197) · Keratoconjunctivitis Sicca (85) · Dry Eye Syndromes (79) · Trachoma (38) · Conjunctivitis, Bacterial (35) · Rhinitis, Allergic (28) · Hypersensitivity (22) · Keratoconjunctivitis (17) · Rhinitis, Allergic, Seasonal (15) · Conjunctivitis, Viral (14) · Asthma (13) · Keratitis (13) · Eye Diseases (10) · Rhinitis (10)
Conjunctival Diseases (426) · Eye Diseases (419) · Immune System Diseases (224) · Hypersensitivity, Immediate (207) · Hypersensitivity (191) · Corneal Diseases (142) · Infections (111) · Keratitis (98) · Lacrimal Apparatus Diseases (98) · Eye Infections (92) · Keratoconjunctivitis (84) · Bacterial Infections and Mycoses (78) · Eye Infections, Bacterial (76) · Bacterial Infections (73)
Olopatadine Hydrochloride (31) · Azithromycin (24) · Ophthalmic Solutions (21) · Lubricant Eye Drops (18) · Loteprednol Etabonate (12) · Dexamethasone (10) · Ketotifen (10) · Cyclosporine (8) · Moxifloxacin (8) · bepotastine besilate (8) · alcaftadine (7) · Cyclosporins (6) · Gatifloxacin (6) · Tacrolimus (6) · besifloxacin (6)
Alcon Research (30) · Bausch & Lomb Incorporated (24) · Allergan (17) · University of California, San Francisco (14) · Johns Hopkins University (10) · ORA, Inc. (9) · Regeneron Pharmaceuticals (9) · Vistakon Pharmaceuticals (9) · ALK-Abelló A/S (8) · Aldeyra Therapeutics, Inc. (7) · Laboratorios Sophia S.A de C.V. (7) · London School of Hygiene and Tropical Medicine (7) · Aciex Therapeutics, Inc. (5) · Laboratoires Thea (5) · National Eye Institute (NEI) (5)
United States (205) · France (19) · Germany (19) · Canada (17) · Italy (17) · Spain (16) · China (13) · United Kingdom (13) · Ethiopia (11) · Japan (11) · Mexico (10) · Israel (9) · Austria (8) · Brazil (8) · South Korea (8)
Gail Torkildsen, MD (6) · Brian Pall, OD, MS, FAAO (4) · Gail L Torkildsen, MD (4) · Abhijit Narvekar, MS, MBBS (3) · Tarek Shazly, MD (3) · Tim McNamara, PharmD (3) · Tom Lietman, MD (3) · Catherine Oldenburg, ScD, MPH (2) · Edward Meier, MD (2) · Elodie Lebas, RN (2) · Emily Gower, PhD (2)
PMID 24836393, PMID 25685162, PMID 31589610, PMID 21681652, PMID 22953007, PMID 22991696, PMID 25260889, PMID 25788949, PMID 26507708, PMID 27466061, PMID 30472141, PMID 15948994, PMID 16021174, PMID 16322853, PMID 16713521, PMID 16877412, PMID 16905024, PMID 17021840, PMID 17054241, PMID 17583820, PMID 17585003, PMID 17652708, PMID 18374301, PMID 18595980, PMID 18677274, PMID 18806663, PMID 19127072, PMID 19302250, PMID 19329003, PMID 19393842, PMID 19506189, PMID 19647862, PMID 19843481, PMID 20304499, PMID 20488431, PMID 20629472, PMID 20631232, PMID 20642205, PMID 20874810, PMID 21072224, PMID 21211642, PMID 21211643, PMID 21250860, PMID 21310379, PMID 21386741, PMID 21397770, PMID 21530362, PMID 21685340, PMID 21771081, PMID 21771118
2008 (2), 2016 (2), 2025 (2), 5UG1EY030833 (2), R01AI048789 (2), 1UG1EY028088 (1), 1UG1EY036891 (1), 2005 (1), 2018 (1), 2019 (1), K23EY019881 (1), R01EY012526 (1), R34EY017626 (1), U10EY022584 (1), U10EY023939 (1)